Bafna Pharma surges over 8% on stake sale reportsMylan and two Indian companies are in the race to acquire the company, which makes haemoglobin drug 'Raricap' among other products.
Stocks in news: Tata Power, Bharti Airtel, Bafna Pharma, United SpiritsStock-specific action is expected in the following stocks on the back of newsflow.
Mylan, two Indian companies line up to buy Bafna PharmaceuticalsDeal size likely to be around 1.7% of the company's annual revenue; sale to help Chennai-based drug maker get rid of its Rs 100-crore debt.
Bafna Pharma launches pain management and anti-infective productsBafna Pharmaceuticals today said it has launched pain management and anti-infective products in the domestic market.
Bafna Pharmaceuticals recommends 6% dividend for 2012-13The Board of Directors of Bafna Pharmaceuticals at its meeting held on May 20, 2013 have recommended 6% dividend.